Atrial septal defects (ASD) are congenital malformations characterized by the presence of an abnormal communication between the right and left atrium. This anomaly allows the passage of oxygenated blood from the left atrium to the right atrium, causing a left-to-right shunt and volume overload in the right heart sections and the lungs. Although small ASDs may remain clinically silent for years, larger defects can lead to significant hemodynamic complications if not treated promptly.
Atrial septal defects account for about 10% of congenital heart diseases diagnosed in childhood and adulthood. The estimated prevalence is approximately 1 in 1500 live births. In adult patients, ASDs may be discovered incidentally or present with symptoms such as fatigue, supraventricular arrhythmias, and in more advanced cases, right heart failure.
The etiology of atrial septal defects is closely related to disturbances in the complex embryogenetic processes that regulate the formation of the interatrial septum. During fetal development, between the fourth and sixth weeks of gestation, the septum primum and septum secundum must grow and fuse properly to completely separate the atria. Errors in these mechanisms can lead to different types of ASD.
The main types of defects include:
In some cases, the presence of a patent foramen ovale (PFO) may be interpreted as a minor form of ASD, although from a pathophysiological perspective, it is a functional rather than anatomical defect.
The main pathophysiological mechanism of ASDs is the left-to-right shunt, where oxygenated blood flows abnormally from the left atrium to the right atrium. This leads to an increase in blood volume reaching the right ventricle and pulmonary circulation, progressively causing right atrial and ventricular dilation, right ventricular hypertrophy, and increased pulmonary vascular resistance.
Initially, the volume overload is well tolerated due to the compliance of the right ventricle and pulmonary vasculature. However, over the years, the persistence of the shunt leads to irreversible structural and functional alterations. Chronic increased pulmonary flow can lead to the development of pulmonary hypertension, with a progressive decrease in the pressure gradient between the left and right atrium. In advanced cases, a shunt reversal (right-to-left) may occur, resulting in Eisenmenger syndrome, an irreversible condition with severe hemodynamic and hypoxemic consequences.
From a hemodynamic perspective, the severity of the ASD depends on:
Normally, the foramen ovale functionally closes at birth due to increased left atrial pressure. However, in neonates with left ventricular dysfunction or persistent pulmonary hypertension, maintaining a right-to-left flow through a PFO may provide temporary protective value. In the context of a true ASD, however, the interatrial communication is pathological and requires definitive closure.
Atrial septal defects are congenital conditions, with their occurrence linked to genetic, environmental, or random embryonic events. In most cases, ASDs occur sporadically with no clearly identifiable cause. However, certain conditions are associated with an increased risk of developing the malformation.
Predisposing factors include specific genetic anomalies, such as mutations in the NKX2-5 and GATA4 genes, which are involved in fetal cardiac development. Chromosomal syndromes, particularly Down syndrome, significantly increase the risk of septum primum defects. Intrauterine exposure to teratogenic substances (alcohol, anticonvulsant drugs, viral infections) and poorly controlled maternal diabetes are additional risk factors, though less frequently correlated.
Prevention of atrial septal defects is complex. Optimal control of pre-existing maternal diseases, folic acid supplementation before conception, avoidance of exposure to known teratogens, and adequate obstetric management during pregnancy are the main strategies to reduce risk, though they do not guarantee absolute prevention.
The clinical manifestation of atrial septal defects is highly variable, depending on the defect size, the volume of the shunt, and the ability of the right heart sections to adapt. Patients with small ASDs may remain asymptomatic throughout life, while in cases of significant shunt, symptoms typically appear in young adulthood or later in life.
On history, patients may report progressive exertional dyspnea, initially with moderate activity and later at rest. Early fatigue is a typical symptom, resulting from reduced pulmonary circulation efficiency. Palpitations are common and often represent atrial arrhythmias secondary to right atrial dilation. In children, a history of recurrent respiratory infections may suggest chronic increased pulmonary flow. In more advanced cases, signs of right heart failure such as peripheral edema and hepatic congestion may be present.
Physical examination provides important diagnostic clues. Cardiac auscultation often reveals a systolic ejection murmur at the second left intercostal space, associated with a fixed splitting of the second heart sound. This sign is particularly pathognomonic for a hemodynamically significant atrial shunt, as the splitting of the second heart sound does not vary with respiration.
In cases of chronic right heart overload, jugular venous distention, painful hepatomegaly, and peripheral edema may be observed. In severe pulmonary hypertension cases, a pronounced pulmonary second heart sound and the presence of functional tricuspid regurgitation murmur can be appreciated.
The suspicion of atrial septal defect should arise when auscultatory findings are suggestive, in the presence of right heart failure symptoms in young individuals or the occurrence of supraventricular arrhythmias without an apparent cause. Cardiomegaly or pulmonary overload detected on chest X-ray should also prompt further diagnostic evaluation.
Transthoracic echocardiography is the first-level diagnostic tool. It allows direct visualization of the defect, documentation of the shunt direction and extent using color Doppler, and assessment of right heart dilation. The presence of a dilated inferior vena cava and increased pulmonary flow are additional indirect findings.
In cases where the acoustic window is suboptimal, transesophageal echocardiography offers superior resolution, allowing detailed anatomical characterization of the defect and the identification of associated venous anomalies. Transesophageal echocardiography is also essential for planning percutaneous closure using occlusive devices.
Cardiac magnetic resonance is indicated in complex cases or when echocardiography is contraindicated. It provides precise assessment of ventricular volumes and quantifies the shunt with the Qp/Qs ratio. Cardiac catheterization is reserved for cases where pulmonary pressures need to be directly measured or to confirm the indication for closure in the presence of pulmonary hypertension.
The diagnostic approach should follow a logical sequence: clinical evaluation guides transthoracic echocardiography; if necessary, transesophageal echocardiography is performed for better anatomical definition; finally, advanced methods such as MRI or cardiac catheterization are used only in complex or uncertain cases. Accurate definition of defect size, shunt direction, and pulmonary pressures is essential for an appropriate therapeutic strategy.
The therapeutic management of atrial septal defects depends on defect size, shunt magnitude, and the presence or absence of associated complications. In patients with modest shunt and no signs of hemodynamic overload, a conservative approach with periodic echocardiographic follow-up is appropriate.
Defect closure is indicated when the Qp/Qs ratio exceeds 1.5:1 with right heart dilation or symptoms attributable to the shunt. The intervention aims to prevent progression to pulmonary hypertension, arrhythmias, and right heart failure.
Percutaneous closure with occlusion devices is the treatment of choice for most secundum-type ASDs. The procedure is performed under echocardiographic and fluoroscopic guidance, with femoral venous access. Modern devices ensure a high success rate and low complication rates. Percutaneous closure is contraindicated in large defects without adequate margins or associated with complex anatomical anomalies.
Surgical closure is reserved for cases where percutaneous intervention is not feasible or contraindicated. The procedure is performed under cardiopulmonary bypass, with direct closure of the defect or via a synthetic or biological patch. Mortality is very low in specialized centers, and long-term results are excellent, with normalization of right heart morphology and function.
The prognosis for patients with early corrected atrial septal defects is generally excellent. Closure of the defect, if performed before the development of severe pulmonary hypertension or significant right ventricular dysfunction, allows complete restoration of normal hemodynamics. Patients treated early exhibit survival rates similar to the general population.
In untreated or late-diagnosed cases, the risk of long-term complications is high. Chronic dilation of the right heart chambers predisposes to atrial arrhythmias, especially atrial fibrillation and flutter, which may persist even after defect closure. Additionally, progressive pulmonary hypertension, if established, can evolve into Eisenmenger syndrome, an irreversible condition with poor prognosis.
The main complications associated with untreated atrial septal defects include: